GOSS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

23.91

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

-3.74

EPS Last/This Y

41.99

EPS This/Next Y

2.4

Price

11.13

Target Price

83.4

Analyst Recom

2.25

Performance Q

-8.88

Upside

-14,458.1%

Beta

2.26

Ticker: GOSS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	GOSS	8.9	0.07	0.00	66667
2026-10-15	GOSS	8.87	0.07	0.00	66631
2026-10-16	GOSS	8.67	0.07	999.99	66630
2026-10-19	GOSS	8.35	0.07	9.00	66630
2026-10-20	GOSS	9.52	0.07	0.00	66415
2026-10-21	GOSS	9.93	0.07	0.00	66420
2026-10-22	GOSS	9.44	0.07	999.99	66421
2026-10-23	GOSS	9.78	0.07	999.99	66421
2026-10-26	GOSS	9.22	0.07	0.00	66334
2026-10-27	GOSS	9.65	0.07	0.00	66334
2026-10-28	GOSS	10.79	0.07	0.00	66334
2026-10-29	GOSS	10.64	0.07	0.00	66334
2026-10-30	GOSS	10.32	0.07	0.00	66332
2026-11-02	GOSS	9.39	0.07	0.00	66331
2026-11-03	GOSS	9.28	0.07	0.10	66325
2026-11-04	GOSS	9.93	0.07	999.99	66318
2026-11-05	GOSS	9.54	0.07	0.02	66316
2026-11-06	GOSS	9.96	0.07	0.00	66305
2026-11-09	GOSS	10.48	0.07	0.06	66310
2026-11-10	GOSS	11.26	0.07	0.00	66308
2026-11-11	GOSS	11.63	0.07	0.00	66308
2026-11-12	GOSS	11.12	0.07	0.00	66298
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	GOSS	8.94	76.6	-	-18.01
2026-10-15	GOSS	8.88	76.6	-	-18.01
2026-10-16	GOSS	8.76	76.6	-	-18.01
2026-10-19	GOSS	8.42	76.6	-	-18.01
2026-10-20	GOSS	8.42	76.6	-	-18.01
2026-10-21	GOSS	9.59	76.6	-	-18.01
2026-10-22	GOSS	9.44	76.6	-	-18.01
2026-10-23	GOSS	9.67	76.6	-	-18.01
2026-10-26	GOSS	9.22	76.6	-	-18.01
2026-10-27	GOSS	9.71	76.6	-	-18.01
2026-10-28	GOSS	10.73	76.6	-	-18.01
2026-10-29	GOSS	10.67	76.6	-	-18.01
2026-10-30	GOSS	10.38	76.6	-	-18.01
2026-11-02	GOSS	9.38	76.6	-	-18.01
2026-11-03	GOSS	9.31	76.6	-	-18.01
2026-11-04	GOSS	9.95	76.6	-	-18.01
2026-11-05	GOSS	9.44	76.6	-	-18.01
2026-11-06	GOSS	9.75	76.6	-	-18.01
2026-11-09	GOSS	10.60	76.6	-	-18.01
2026-11-10	GOSS	11.25	76.6	-	-18.01
2026-11-11	GOSS	11.68	76.6	-	-18.01
2026-11-12	GOSS	11.13	76.6	-	-18.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	GOSS	0.00	0	22.10
2026-10-15	GOSS	0.00	0	22.10
2026-10-16	GOSS	0.00	0	22.10
2026-10-19	GOSS	0.00	10.16	22.10
2026-10-20	GOSS	0.00	10.16	22.10
2026-10-21	GOSS	0.00	10.16	22.10
2026-10-22	GOSS	0.00	10.16	22.10
2026-10-23	GOSS	0.00	10.16	22.10
2026-10-26	GOSS	0.00	36.70	22.10
2026-10-27	GOSS	0.00	36.70	25.65
2026-10-28	GOSS	0.00	36.70	25.65
2026-10-29	GOSS	0.00	36.70	25.65
2026-10-30	GOSS	0.00	36.70	25.65
2026-11-02	GOSS	0.00	36.72	25.65
2026-11-03	GOSS	0.00	36.72	25.65
2026-11-05	GOSS	0.00	36.72	25.65
2026-11-06	GOSS	0.00	36.72	25.65
2026-11-09	GOSS	0.00	56.39	25.65
2026-11-10	GOSS	0.00	56.39	25.65
2026-11-11	GOSS	0.00	56.39	23.91
2026-11-12	GOSS	0.00	56.39	23.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.19

Avg. EPS Est. Current Quarter

-3.93

Avg. EPS Est. Next Quarter

-4.93

Insider Transactions

Institutional Transactions

56.39

Beta

2.26

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.1

Max Drawdown 5-Year %

-99.3

Target Price

83.4

P/E

Forward P/E

PEG

P/S

0.88

P/B

P/Free Cash Flow

EPS

-46.11

Average EPS Est. Cur. Y

-18.01

EPS Next Y. (Est.)

-15.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-159.49

Relative Volume

0.73

Return on Equity vs Sector %

75.5

Return on Equity vs Industry %

94.9

EPS 1 7Days Diff

-1.7

EPS 1 30Days Diff

-3.61

EBIT Estimation

◆ GOSS Healthcare

$11.24

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

6/25

Volume

9/15

Valuation

12/20

TP/AR

5/10

Options

8/10

RSI

57.1

Range 1M

72.6%

Sup Dist

8.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

26/30

Estimates

6/20

Inst/Vol

5/15

Options

6/10

EPS Yr

73.7%

EPS NY

59.1%

52W%

0.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +642% upside

Quality

8/30

Valuation

16/30

Growth

22/25

Stability

6/10

LT Trend

3/5

Upside

+642%

Quality

GOSS — P/E HistoricalBiotechnology

Gossamer Bio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 161

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

GOSS

Latest News

—

Caricamento notizie per GOSS…

stock quote shares GOSS – Gossamer Bio, Inc. Stock Price stock today

news today GOSS – Gossamer Bio, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch GOSS – Gossamer Bio, Inc. yahoo finance google finance

stock history GOSS – Gossamer Bio, Inc. invest stock market

stock prices GOSS premarket after hours

ticker GOSS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GOSS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y